首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 生物科技 > 生物材料 > 透明質酸為基礎的美國生物材料市場
產業/市場分類
生物科技 (1470)
分子標靶治療學 (51)
生技設備 (321)
生物材料 (55)
生物標記 (157)
以基因為基之藥物開發 (201)
再生醫學 (120)
抗體和免疫 (187)
個人化醫學 (54)
基因治療學和RNAi (101)
市場調查報告書

透明質酸為基礎的美國生物材料市場

U.S. Markets for Biomaterial Applications of Hyaluronic Acid (HA)

出版商 Frost & Sullivan
出版日期 2004年09月 商品編碼 24085
內容資訊 英文  
價格
本報告書已不再販售

本報告已在2011年07月19日停止出版。

簡介

以透明質酸為基礎的生物材料市場因為產品可以運用在許多用途上,所以隨著人口高齡化、製品改良,需求的增加以及市場的擴大未來性是可以預料得到的。

專門在高科技領域裡,從事諮詢及市場調查的美國市調公司 Frost & Sullivan (總公司: 德州),詳盡地調查與分析美國的透明質酸生物材料市場,並有系統地出版綜合報告書“U.S. Markets for Biomaterial Applications of Hyaluronic Acid (HA)”

此報告書在下面的內容裡,除了說明透明質酸為基礎的美國生物材料應用市場(黏彈性補充療法、眼科手術用補助劑、整形移植、手術後抗組織沾黏材料)的動向;也探討包括主要企業的市場佔有及獲利的競爭分析、與未來市場的預測等。

1. 透明質酸為基礎的整體生物材料市場

  • 概要
  • 調查區塊
  • 預測與動向概要
  • Frost & Sullivan Awards

2. 退化性關節炎的黏彈性補充療法製品市場

  • 概要
    • 開發
    • 詳細狀況
    • 市場促進因素
  • 黏彈性補充療法製品市場的預測與動向
    • 假說
    • 製程預測
    • 價格預測
    • 獲利預測
  • 黏彈性補充療法製品市場的競爭分析
    • 市場佔有分析
    • Genzyme 與 Wyeth 的合作關係
    • Fidia 與 Sanofi-Synthelabo 的合作關係
    • 生化工學與 Smith & Nephew 的合作關係
    • Anika Therapeutics 與 Ortho Biotech 的合作關係

3. 眼科手術用補助劑市場

  • 概要
    • 開發
    • 詳細狀況
    • 市場促進因素
  • 眼科手術用補助劑市場的預測與動向
    • 假說
    • 出貨量預測
    • 價格預測
    • 獲利預測
  • 眼科手術用補助劑市場的競爭分析
    • 市場佔有率分析
    • Alcon
    • Advanced Medical Optics (AMO)
    • Bausch & Lomb

4. 整形移植市場

  • 概要
    • 開發
    • 詳細狀況
    • 市場促進因素
  • 整形移植市場的預測與動向
    • 假說
    • 出貨量預測
    • 價格預測
    • 獲利預測
  • 整形移植市場的競爭分析
    • 市場佔有分析
    • Inamed Corporation
    • Medicis Pharmaceutical Corporation

5. 手術後抗組織沾黏材料市場

  • 概要
    • 開發
    • 詳細狀況
    • 市場促進因素
  • 手術後抗組織沾黏材料市場的預測與動向
    • 假說
    • 出貨量預測
    • 價格預測
    • 獲利預測
  • 手術後抗組織沾黏材料市場的競爭分析
    • 市場佔有率分析
    • Genzyme

6. 輔助決策資料庫

  • 亞洲各國統計
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國

目錄

Research Overview

Hyaluronic Acid-based Biomaterials Pervade the Healthcare Industry

Hyaluronic acid (HA)-based biomaterials have wide-ranging applications in the healthcare industry. The materials derived from HA are being used to relieve the pain of knee osteoarthritis, in cataract surgeries, in abdominal and pelvic surgeries, and as a dermal filler to erase facial wrinkles. Moreover, an aging population, several product innovations, and underserved end-user segments are creating a huge market for HA-based biomaterials. Some existing end users include rheumatologists, ophthalmologists, plastic and reconstructive surgeons, anti-adhesive wound care specialists, and gynecologists.

This Frost & Sullivan strategic analysis service provides an overview of and an outlook for the U.S. biomaterial applications of hyaluronic acid. The study is segmented into viscosupplementation products for osteoarthritis, viscoelastic products for ophthalmic applications, facial aesthetic implants, and post-surgical anti-adhesion barriers. It enables the development of growth strategies to enhance companiesf market shares and revenue.

HA-based Biomaterials Need a Dose of Innovation to Stay Ahead

Many market segments where HA-based biomaterials have become firmly entrenched are facing increasing reimbursement pressure from Medicare and other healthcare providers. An example is the lower reimbursements for physicians for cataract surgeries, who, in turn, want reduced prices for HA-based viscoelastics. Medicare is also cutting reimbursements of viscosupplementation procedures using HA-based material for knee osteoarthritis. These market segments have not seen significant recent innovation with HA-based biomaterials. The market also needs to fight price erosion by adding value to its products.

Some market participants are already planning to develop the next generation of viscosupplements as good carriers for drug delivery. Medical device manufacturers can also fund research to unravel the mechanism of viscosupplements. "Once this is done, it will boost physician confidence leading to increased use of this procedure," says the analyst. Product manufacturers and marketers are also likely to ensure that their products maintain the value-to-price ratio in order to gain wide customer appeal.

Demand Expected to be Buoyed by Aging Baby Boomers

The number of people above 65 years is expected to more than double from 35 million in 2000 to 71 million in 2020 in the United States. People in this age group will be entering a stage where the incidence of osteoarthritis, cataract, and facial wrinkles increases. HA-based biomaterials have a significant role to play in the treatment of all these afflictions. Thus, the demand for HA-based biomaterials is expected to be spurred by the aging demographics.

Since the knee osteoarthritis patient population is expected to increase by 26 percent from 15 million in 2000 to 19 million in 2010, viscosupplements can expect an escalation in demand. Apart from a huge market for osteoarthritis medication, the post-surgical anti-adhesion barrier market also carries a huge potential. Internal adhesions after abdominal surgeries can cause problems, such as bowel obstruction and pain. "Due to the critical nature of these complications, surgeons are demanding anti-adhesion barriers that perform consistently," notes the analyst. Adhesion lysis surgeries are performed more frequently on those above 65 years than on younger age groups.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivan's GPS includes:

  • Assisting companies to reach their full potential in the core business
  • Providing growth strategies to help companies expand into related businesses
  • Preemptively redefining the core business during market turbulence
  • Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
  • Recommending growth management strategies through continuous partnership

To maximize the potential for growth within a firmfs internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivanfs strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clientsf growth.

1 TOTAL HYALURONIC ACID-BASED BIOMATERIALS MARKETS

  • Executive Summary and Overview
    • Executive Summary
    • Overview
    • Major Participants in this Industry
  • Research Segmentation
    • Segmentation by Product
    • Segmentation by End User
  • Forecasts and Trends
    • Market Drivers
    • Market Challenges
    • Revenue Forecasts
  • Frost & Sullivan Market Engineering Awards
    • Frost & Sullivan Award for Product Differentiation Innovation
    • Frost & Sullivan Award for Entrepreneurial Company
    • Frost & Sullivan Award for Product Line Strategy
    • Frost & Sullivan Award for Competitive Strategy Leadership

2 OSTEOARTHRITIS VISCOSUPPLEMENTATION PRODUCTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Osteoarthritis Viscosupplementation Forecasts and Trends
    • Assumptions
    • Procedure Forecast
    • Pricing Forecast
    • Revenue Forecast
  • Osteoarthritis Viscosupplementation Competitive Analysis
    • Market Share Analysis
    • Genzyme and Wyeth Partnership
    • Fidia and Sanofi-Synthelabo Partnership
    • Seikagaku and Smith & Nephew Partnership
    • Anika Therapeutics and Ortho Biotech Partnership

3 OPHTHALMIC VISCOELASTIC PRODUCTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Opthalmic Viscoelastics Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Ophthalmic Viscoelastics Competitive Analysis
    • Market Share Analysis
    • Alcon
    • Advanced Medical Optics (AMO)
    • Bausch & Lomb

4 FACIAL AESTHETIC IMPLANTS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Facial Aesthetics Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Facial Aesthetics Competitive Analysis
    • Market Share Analysis
    • Inamed Corporation
    • Medicis Pharmaceutical Corporation

5 POST-SURGICAL ANTI-ADHESION BARRIERS MARKET

  • Overview
    • Development
    • Description
    • Market Drivers
    • Market Challenges and Strategies
  • Forecasts and Trends
    • Assumptions
    • Unit Shipment Forecasts
    • Pricing Forecasts
    • Revenue Forecasts
  • Competitive Analysis
    • Market Share Analysis
    • Genzyme

6 DECISION SUPPORT TABLES

  • Statistics on Asian Countries
    • Australia
    • China
    • India
    • Japan
    • South Korea
Back to Top